In the context of improving antimicrobial therapy decisions, which factor is linked to receiving results faster?

• A. Pharmacist-driven reporting
• B. De-escalation by half time
• C. Patient-portable results
• D. Automated reporting only

Answer: (A)

The key idea is that getting faster antimicrobial decisions relies on timely, proactive communication within the care team. Pharmacist-driven reporting puts a pharmacist in charge of relaying lab results quickly and translating them into actionable steps for clinicians. This means urgent results are highlighted, interpreted in the clinical context, and paired with concrete recommendations right away, so teams can adjust therapy without waiting for multiple handoffs or approvals. That direct, real-time coordination speeds up when and how therapy changes are made.

Other ideas describe outcomes or technologies that help, but they don’t inherently speed up the initial receipt and interpretation of results. De-escalation by half time reflects how quickly therapy is narrowed after decisions are made, not how fast results are reported. Patient-portable results focus on patient access rather than clinician notification. Automated reporting can reduce manual steps, but without active, trained interpretation and prioritization, there can still be delays in delivering timely, actionable guidance.